(Q35820582)

10 August 2017

In vitro and in vivo evaluations of A-80556, a new fluoroquinolone (English)

1 reference

10 August 2017

Clement JJ

1

1 reference

10 August 2017

Tanaka SK

2

1 reference

10 August 2017

Alder J

3

1 reference

10 August 2017

Vojtko C

4

1 reference

10 August 2017

Beyer J

5

1 reference

10 August 2017

Hensey D

6

1 reference

10 August 2017

Ramer N

7

1 reference

10 August 2017

McDaniel D

8

1 reference

10 August 2017

Chu DT

9

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 May 1994

1 reference

Antimicrobial Agents and Chemotherapy

10 August 2017

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

10 August 2017

38

1 reference

10 August 2017

5

1 reference

10 August 2017

1071-1078

1 reference

Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188152

In vitro activity of lomefloxacin, a new quinolone antimicrobial agent, in comparison with those of other agents

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188152

Multicenter in vitro evaluation of lomefloxacin (NY-198, SC-47111), including tests against nearly 7,000 bacterial isolates and preliminary recommendations for susceptibility testing.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188152

Quinolones in the treatment of lower respiratory tract infections

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188152

Comparative in vitro activities of several new fluoroquinolones and beta-lactam antimicrobial agents against community isolates of Streptococcus pneumoniae

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188152

In-vitro activity of sparfloxacin, a new quinolone antimicrobial agent

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188152

Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in an acute-care hospital

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188152

Activity of temafloxacin against respiratory pathogens

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188152

Comparative activity of fluorinated quinolones in acute and subacute Streptococcus pneumoniae pneumonia models: efficacy of temafloxacin

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188152

The in-vitro activity of temafloxacin compared with other antimicrobial agents

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188152

Fluoroquinolone resistance an evolving national problem or just a problem for some physicians?

11 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8067740

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Comparative chemotherapeutic activity of temafloxacin, cefoxitin, clindamycin, imipenem and ampicillin/sulbactam against Bacteroides fragilis in a mouse subcutaneous abscess model

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8067740

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.38.5.1071

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

8067740

1 reference